Medscape InDiscussion: Pulmonary Arterial Hypertension

Medscape•www.medscape.com

Join Dr Vallerie McLaughlin for Medscape InDiscussion: Pulmonary Arterial Hypertension, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968545). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

Last refreshed: April 27th, 2026 at 1:21 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

The 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension With First Author, Marc Humbert

Drs Vallerie McLaughlin and Marc Humbert discuss the 2022 guidelines on pulmonary arterial hypertension by the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968551). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources Pulmonary Arterial Hyp...

Oct 20, 2022•25 min

Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension

Drs Vallerie McLaughlin and Richard Channick discuss the diagnosis and treatment of chronic thromboembolic pulmonary hypertension. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968550). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources Pulmonary Hypertension https://www.medscape.com/answers/303098-93380/what-is-pulmon...

Sep 22, 2022•23 min

Identifying and Navigating Challenging Clinical Scenarios in Pulmonary Arterial Hypertension

Drs Vallerie McLaughlin and Oksana Shlobin discuss methods of identifying and navigating challenging clinical scenarios in pulmonary arterial hypertension. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968548). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources What Is Pulmonary Hypertension? https://www.medscape.com/a...

Aug 25, 2022•21 min

Pulmonary Arterial Hypertension Risk Stratification

Drs Vallerie McLaughlin and Ioana Preston discuss how equations and prediction models guide risk stratification of patients diagnosed with pulmonary arterial hypertension. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968547). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources Pulmonary Arterial Hypertension https://em...

Jul 21, 2022•24 min

Diagnosis of PAH: What Are the Causes and Why Does It Take So Long?

Drs Vallerie McLaughlin and Paul Forfia discuss the diagnosis of PAH. What are the causes and why does it take so long? Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/968546). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources Pulmonary Arterial Hypertension https://emedicine.medscape.com/article/303098-overview The...

Jun 23, 2022•23 min

Classifications and Causes of Pulmonary Hypertension

This episode explores the complex world of pulmonary hypertension (PH), detailing the updated hemodynamic definitions for PH and pulmonary arterial hypertension (PAH). Drs. McLaughlin and Benza walk through the five classifications, highlighting Group 2 PH (left heart disease) with a focus on HFpEF diagnosis and the importance of differentiating it from Group 1. They also cover Group 3 (lung diseases), Group 4 (CTEPH), Group 5 (rare causes), and various etiologies within Group 1, including genetic factors, connective tissue diseases, and portal hypertension. The discussion concludes with insights into exciting future advancements in PAH treatment and management strategies.

Jun 23, 2022•23 min

Hosted on Libsyn

For the best experience, listen in Metacast app for iOS or Android